New Stem Cells Cure Disorder in Mice
The findings demonstrate how these cells could be used in human therapies
Source: “Treatment of sickle cell anemia mouse model with IPS cells generated from autologous skin”
Tim M. Townes, Rudolf Jaenisch, et al.
Science 318: 1920-1923, published online December 6, 2007
Results: Scientists have cured a blood disease in mice using cells from the animals’ tails. A new technique that does not require the use of embryos enabled the researchers to reprogram the cells to behave like embryonic stem cells.
Why it matters: The findings are the first to demonstrate the potential of such cells, known as induced pluripotent cells, in treating disease. The cells have been the source of great excitement among both researchers and the public because they hold therapeutic promise and because they sidestep the major ethical concern associated with embryonic stem cells: the destruction of embryos.
Methods: Rudolf Jaenisch and his colleagues at the Whitehead Institute for Biomedical Research in Cambridge, MA, reprogrammed the mouse tail cells to express four genes that are normally active only during embryonic development. After correcting the genetic defect responsible for sickle-cell anemia, they treated the cells with growth factors to trigger the development of blood-forming stem cells. Mere days after the researchers injected the stem cells into the animals’ bone marrow, symptoms of the disease had reversed.
Next steps: Scientists are concerned that the mechanism used to reprogram the cells to make them pluripotent could increase the risk of cancer. To make the cells safe for human use, the researchers are developing alternative methods.